HATI-CANCER
Hati-Cancer is developing new drugs for metastatic cancer targeted therapy. The company was composed of 4 founders: Bruno Azevedo (CEO), Miguel Sousa (CTO), Ricardo Soares (COO), Rodrigo Pires (CCO), who are all Electrical Engineers.
HATI-CANCER
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Status:
Active
Total Funding:
100 K EUR
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Riptide Bioscience
Riptide Bioscience is developing medicines with lifesaving potential.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Current Employees Featured
Founder
Investors List
Portugal Ventures
Portugal Ventures investment in Venture Round - Hati-Cancer